In the MMR-deficient subgroup, estimates were directionally similar but underpowered; nonetheless, there was no statistically significant heterogeneity in the association of tumor proliferation rate with survival by MMR status in either cohort (Pinteraction > 0.49). Here, MRC1 is linked to neoplasm.